清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

The results of the treatment of childhood medulloblastoma with radiotherapy at Kaunas University of Medicine Hospital in 1994-2000.

作者
Giedrė Rutkauskienė,Liutauras Labanauskas,Laimonas Jaruševičius
出处
期刊:PubMed [National Institutes of Health]
卷期号:42 (1): 22-32 被引量:5
标识
摘要

UNLABELLED: Medulloblastoma, a primitive neuroectodermal tumor growing in cerebellum, is one of the most sensitive to radiation therapy childhood brain tumors, therefore, this method of treatments is justly considered to be the standard for the treatment of medulloblastoma. The outcome of this malignant brain tumor differs in standard and high-risk groups of patients. The aim of the work was to evaluate the survival rate for children with medulloblastoma according to two risk groups. PATIENTS AND METHODS: Eighteen patients aged from 3 to 18 years with histological proven medulloblastoma treated with standard craniospinal and additional posterior fossa radiotherapy were investigated in our study. Nine patients with disseminated and partial removed medulloblastoma were assigned to the high-risk group and other 9 patients with local ant totally removed medulloblastoma were allocated to the standard risk group. RESULTS: Radiological response of medulloblastoma to the radiation therapy was observed in 15 (83.3%) out of 18 patients: complete radiological response was observed in 6 (67%) out of 9 standard-risk patients and in only 1 (11.1%) out of 9 high-risk patients (p<0.05). Medulloblastoma progressed in 15 (83.3%) patients treated with radiation therapy: relapse rate in the high-risk group was 100% and in the standard-risk group--66.7% (p>0.05). The mean time to progression for all patients was 18.2 months: 28.9 months in standard and 7.4 months in high-risk group (p=0.02). The overall survival for all investigated patients was 25.8 months: 37.2 and 14.3 months in the standard and high-risk groups, respectively (p=0.01). Five years progression-free and overall survival rate for all patients was 16.7%: 0% in the high-risk group and 33.3 % in the standard-risk group (p>0.05). CONCLUSION: In our study the difference in survival rate between standard and high-risk patients with medulloblastoma was shown. We observed a statistically significant longer time to progression and better overall survival in the standard-risk group. However, we did not find any significant differences in other survival indices (response, relapse rates, mortality, five years progression- free and overall survival) between those two risk groups.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Keyh完成签到,获得积分10
2秒前
7秒前
优美的烙完成签到,获得积分10
10秒前
FODCOC完成签到,获得积分10
13秒前
重要寄瑶完成签到,获得积分10
26秒前
27秒前
贪玩的梦容完成签到,获得积分10
28秒前
amiee发布了新的文献求助30
32秒前
夏日随笔完成签到 ,获得积分10
43秒前
火柴盒完成签到,获得积分10
47秒前
lx完成签到 ,获得积分10
48秒前
xzx完成签到,获得积分10
49秒前
专注寒蕾完成签到,获得积分10
54秒前
58秒前
1分钟前
stanfordlee完成签到,获得积分10
1分钟前
limengyao完成签到,获得积分10
1分钟前
沉静曼梅完成签到,获得积分10
1分钟前
忧郁的芳完成签到,获得积分10
1分钟前
迷你的蜜粉完成签到,获得积分10
1分钟前
英俊的小懒虫完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
勤恳寄凡发布了新的文献求助10
1分钟前
北枳完成签到,获得积分10
1分钟前
2分钟前
2分钟前
清新的之双完成签到,获得积分10
2分钟前
My_magnum_opus发布了新的文献求助100
2分钟前
体贴的惜文完成签到,获得积分10
2分钟前
勤恳寄凡完成签到,获得积分10
2分钟前
炜大的我举报dianeil的求助涉嫌违规
2分钟前
害羞的又菡完成签到,获得积分10
2分钟前
aging完成签到 ,获得积分10
2分钟前
2分钟前
不安溪灵完成签到,获得积分10
3分钟前
3分钟前
祁岳颐完成签到 ,获得积分10
3分钟前
心灵美懿轩完成签到,获得积分10
3分钟前
MassTestA1的应助被MassTestA1采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185453
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834449
捐赠科研通 7782987
什么是DOI,文献DOI怎么找? 3434570
关于科研通互助平台的介绍 2558881
邀请新用户注册赠送积分活动 2481299